Thyroid disease in insulin-treated patients with type 2 diabetes: A retrospective study

被引:14
|
作者
Witting V. [1 ]
Bergis D. [1 ]
Sadet D. [1 ]
Badenhoop K. [1 ]
机构
[1] Department of Internal Medicine 1, Division of Endocrinology and Metabolism, Goethe-University Hospital, 60590 Frankfurt am Main
关键词
Coexistence; Diabetes mellitus; Insulin therapy; Outcome; Thyroid disease;
D O I
10.1186/1756-6614-7-2
中图分类号
学科分类号
摘要
Background: Diabetes mellitus and thyroid diseases frequently coexist. In order to evaluate how thyroid disorders interfere with glycemic control, we analysed insulin-treated type 2 diabetes patients with thyroid disease. Methods. Diabetes patients (n = 1.957) were retrospectively investigated. We focused on type 2 diabetes patients who had been admitted for insulin-treatment and diagnosed thyroid diseases (n = 328). Patients were divided into three groups according to thyroid disease manifestation in relation to diabetes onset: prior to (group 1), same year (group 2) and thyroid disease following diabetes (group 3). Results: Out of all diabetes patients 27.3% had a thyroid disorder with more women (62.2%) being affected (p < 0.001). Thyroid disease was predominantly diagnosed after diabetes onset. Patients with type 2 diabetes and prior appearance of thyroid disease required insulin therapy significantly earlier (median insulin-free period: 2.5 yrs; Q§ssub§1§esub§ = 0.0, Q§ssub§3§esub§ = 8.25) compared to patients who had thyroid dysfunction after diabetes onset (median insulin-free period: 8.0 yrs; Q§ssub§1§esub§ = 3.0, Q§ssub§3§esub§ = 12.0; p < 0.001). Age at diabetes onset correlated with insulin-free period (p < 0.001). Conclusions: Thyroid disease may be a marker of a distinct metabolic trait in type 2 diabetes potentially requiring earlier insulin treatment. © 2014 Witting et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [41] Efficacy of glimepiride in patients with poorly controlled insulin-treated type 2 diabetes mellitus
    Ose, H
    Fukui, M
    Kitagawa, Y
    Hirata, C
    Ichio, N
    Kadono, M
    Mogami, SI
    Onishi, M
    Ichida, Y
    Nakajima, T
    Hasegawa, G
    Yoshikawa, T
    Nakamura, N
    ENDOCRINE JOURNAL, 2005, 52 (05) : 563 - 569
  • [42] Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients
    Hollander, P
    Maggs, DG
    Ruggles, JA
    Fineman, M
    Shen, L
    Kolterman, OG
    Weyer, C
    OBESITY RESEARCH, 2004, 12 (04): : 661 - 668
  • [43] Glycemic Variability as Predictor of Clinical Outcome in Insulin-Treated Patients With Type 2 Diabetes
    Farrokhi, Farnoosh
    Smiley, Dawn
    Pasquel, Francisco
    Peng, Limin
    Newton, Christopher
    Olson, Darin E.
    Jacobs, Sol
    Umpierrez, Guillermo E.
    DIABETES, 2013, 62 : A245 - A245
  • [44] Amputations and mortality in elderly insulin-treated patients with type 2 diabetes - Invited commentary
    Schweiger, H
    ZENTRALBLATT FUR CHIRURGIE, 1999, 124 (06): : 507 - 507
  • [45] Diuretics use and risk of amputation among patients with insulin-treated type 2 diabetes
    Alkharaiji, M.
    Alshnbari, A. S.
    Idris, I.
    DIABETOLOGIA, 2019, 62 : S361 - S361
  • [46] Effect of troglitazone in insulin-treated patients with type II diabetes mellitus
    Schwartz, S
    Raskin, P
    Fonseca, V
    Graveline, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13): : 861 - 866
  • [47] Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin-treated Type 2 diabetes
    Partridge, H.
    Kerr, D.
    DIABETIC MEDICINE, 2009, 26 (12) : 1306 - 1306
  • [48] Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes
    Rudijanto, Achmad
    Saraswati, Made R.
    Yunir, Em
    Kumala, Poppy
    Puteri, Happy H. S.
    Mandang, Veny V. V.
    ACTA MEDICA INDONESIANA, 2018, 50 (01) : 26 - 37
  • [49] Nocturnal hypoglycemia in patients with insulin-treated diabetes
    Yale, JF
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 65 : S41 - S46
  • [50] Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes
    Kishimoto M.
    Noda M.
    Diabetes Therapy, 2012, 3 (1) : 1 - 9